Clinical Trial Update: A Multi-center, Placebo-controlled Study to Evaluate NT100 in Pregnant Women With a History of Unexplained Recurrent Pregnancy Loss (RPL) [Phase 2]

View source ↗

Summary

A Phase 2, multi-center, placebo-controlled clinical trial evaluating NT100 in pregnant women with a history of unexplained recurrent pregnancy loss.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Miscarriage
• Pregnancy Loss

Drugs mentioned

• NT100

Snippet

Sponsor: Nora Therapeutics, Inc. | Conditions: Recurrent Pregnancy Loss, Recurrent Miscarriage | Phase 2 | Status: UNKNOWN